Browsing NTU Scholars | NTU Scholars

Showing results 1 to 20 of 165 next >

Issue Date	Title	Author(s)	Source	scopus	WOS
1994	Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid	KUN-HUEI YEH ; Cheng A.-L.	Journal of the Formosan Medical Association		0
2013	ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers	Liu W.-H.; Chen C.-H.; KUN-HUEI YEH ; Li C.-L.; Wu Y.-J.; Chen D.-S.; Chen P.-J.; Yeh S.-H.	PLoS ONE	20	16
2018	Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: A randomized Phase III study	Li J.; Xu R.; Qin S.; Liu T.; Pan H.; Xu J.; Bi F.; Lim R.; Zhang S.; Ba Y.; Bai Y.; Fan N.; Tsuji A.; KUN-HUEI YEH ; Ma B.; Wei V.; Shi D.; Magherini E.; Shen L.	Future Oncology	7	11
1994	An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2]	KUN-HUEI YEH ; Cheng A.-L.	Journal of Clinical Oncology	18	16
2017	Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review	Chen L.-T.; Oh D.-Y.; Ryu M.-H.; KUN-HUEI YEH ; Yeo W.; Carlesi R.; Cheng R.; Kim J.; Orlando M.; Kang Y.-K.	Cancer Research and Treatment	43	36
2021	Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort	Chen K.-H.; Lin L.-I.; Yuan C.-T.; Tseng L.-H.; Chao Y.-L.; Liang Y.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; KUN-HUEI YEH	British Journal of Cancer		0
2017	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; KUN-HUEI YEH	PLoS ONE	4	3
2016	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	Yang S.-H.; Guo J.-C.; KUN-HUEI YEH ; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.	Journal of Gastroenterology and Hepatology (Australia)	7	7
2017	The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)	Kuo S.-H.; Tsai H.-J.; Lin C.-W.; KUN-HUEI YEH ; Lee H.-W.; Wei M.-F.; Shun C.-T.; Wu M.-S.; Hsu P.-N.; Chen L.-T.; Cheng A.-L.	Journal of Pathology	6	10
2014	Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse	Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH ; Chen L.-T.; Cheng A.-L.	Genes Chromosomes and Cancer	3	3
1998	Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma	Cheng A.-L.; KUN-HUEI YEH ; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; Chen D.-S.	Hepato-Gastroenterology		33
2016	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; KUN-HUEI YEH ; Cheng A.-L.	Medical Oncology	15	14
2016	Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance	Chen K.-H.; Yuan C.-T.; Tseng L.-H.; Shun C.-T.; KUN-HUEI YEH	Journal of Hematology and Oncology	15	13
2015	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; KUN-HUEI YEH	Anticancer Research		4
2021	Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing	Liang Y.-H.; Tsai J.-H.; Cheng Y.-M.; Chan K.-Y.; Hsu W.-L.; Lee C.-C.; Chen K.-H.; KUN-HUEI YEH	Scientific reports		1
2014	Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers	Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; KUN-HUEI YEH	Supportive Care in Cancer	8	10
1996	Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma	Cheng A.-L.; Chen Y.-C.; KUN-HUEI YEH ; Chuang S.-E.; Chen B.-R.; Chen D.-S.	Cancer	37
1998	Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer	Cheng A.-L.; KUN-HUEI YEH ; Lin J.-T.; Hsu C.; Liu M.-Y.	Anticancer Research		20
2002	Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma	Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; KUN-HUEI YEH ; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L.	Leukemia and Lymphoma	9	5
2021	Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas	Ma W.-L.; KUN-HUEI YEH ; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H.	Journal of the Formosan Medical Association	1	0

Showing results 1 to 20 of 165 next >

DSpace CRIS

Browsing by Author